Top-Rated StocksTop-RatedNASDAQ:PRVA Privia Health Group (PRVA) Stock Forecast, Price & News $23.00 0.00 (0.00%) (As of 09/29/2023 ET) Add Compare Share Share Today's Range$22.46▼$23.5250-Day Range$21.63▼$27.9252-Week Range$20.64▼$36.55Volume1.14 million shsAverage Volume1.22 million shsMarket Capitalization$2.70 billionP/E Ratio85.19Dividend YieldN/APrice Target$36.86 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Privia Health Group MarketRank™ ForecastAnalyst RatingBuy3.00 Rating ScoreUpside/Downside60.2% Upside$36.86 Price TargetShort InterestBearish5.86% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.84Based on 4 Articles This WeekInsider TradingSelling Shares$5.23 M Sold Last QuarterProj. Earnings Growth31.82%From $0.22 to $0.29 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.91 out of 5 starsMedical Sector48th out of 973 stocksHealth Services Industry1st out of 14 stocks 3.5 Analyst's Opinion Consensus RatingPrivia Health Group has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 10 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $36.86, Privia Health Group has a forecasted upside of 60.2% from its current price of $23.00.Amount of Analyst CoveragePrivia Health Group has only been the subject of 2 research reports in the past 90 days. Previous Next 2.0 Short Interest Percentage of Shares Shorted5.86% of the float of Privia Health Group has been sold short.Short Interest Ratio / Days to CoverPrivia Health Group has a short interest ratio ("days to cover") of 6.2.Change versus previous monthShort interest in Privia Health Group has recently decreased by 4.52%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldPrivia Health Group does not currently pay a dividend.Dividend GrowthPrivia Health Group does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for PRVA. Previous Next 3.2 News and Social Media Coverage News SentimentPrivia Health Group has a news sentiment score of 0.84. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.68 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Privia Health Group this week, compared to 3 articles on an average week.Search Interest1 people have searched for PRVA on MarketBeat in the last 30 days. MarketBeat FollowsOnly 1 people have added Privia Health Group to their MarketBeat watchlist in the last 30 days. This is a decrease of -75% compared to the previous 30 days. Previous Next 4.2 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Privia Health Group insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $5,229,950.00 in company stock.Percentage Held by Insiders57.60% of the stock of Privia Health Group is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions92.40% of the stock of Privia Health Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 3.1 Earnings and Valuation Earnings GrowthEarnings for Privia Health Group are expected to grow by 31.82% in the coming year, from $0.22 to $0.29 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Privia Health Group is 85.19, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 111.42.Price to Earnings Ratio vs. SectorThe P/E ratio of Privia Health Group is 85.19, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 99.80.Price to Earnings Growth RatioPrivia Health Group has a PEG Ratio of 2.85. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioPrivia Health Group has a P/B Ratio of 5.08. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Privia Health Group (NASDAQ:PRVA) StockPrivia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia. Privia Health Group, Inc. is a subsidiary of Brighton Health Group Holdings, LLC.Read More PRVA Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PRVA Stock News HeadlinesSeptember 24, 2023 | americanbankingnews.comCritical Analysis: Privia Health Group (NASDAQ:PRVA) versus DocGo (NASDAQ:DCGO)September 21, 2023 | americanbankingnews.comPrivia Health Group, Inc. (NASDAQ:PRVA) Receives Average Rating of "Buy" from AnalystsSeptember 30, 2023 | Legacy Research (Ad)ATTENTION: Digital Dollar Could Send this $0.25 Play SkyrocketingIn just a few days, the U.S. government could announce this mandatory recall on the U.S. dollar… And replace it with a new digital dollar. And that could send this $0.25 alternative investment skyrocketing.September 14, 2023 | finance.yahoo.comBe Wary Of Privia Health Group (NASDAQ:PRVA) And Its Returns On CapitalSeptember 6, 2023 | finance.yahoo.comPrivia Health to Participate in the Morgan Stanley Healthcare ConferenceAugust 25, 2023 | finance.yahoo.comPrivia Health Reports Results in CMS’ Medicare Shared Savings Program for the 2022 Performance YearAugust 25, 2023 | finance.yahoo.comPrivia Health Reports Results in CMS’ Medicare Shared Savings Program for the 2022 Performance YearAugust 19, 2023 | markets.businessinsider.com4 Analysts Have This to Say About Privia Health GrSeptember 30, 2023 | MarketBeat Internal (Ad)MarketBeat's Top 5 Stock Picks - Just ReleasedMarketBeat has just released five new trading ideas to All Access subscribers, but Tesla, Apple, and Netflix didn't make the cut. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. Now, MarketBeat thinks these five stocks may be even better buys. August 17, 2023 | finance.yahoo.comGEHC or PRVA: Which Is the Better Value Stock Right Now?August 16, 2023 | msn.comPrivia Health: Unit Economics Stretching Higher At Qualified Growth Rates (Rating Upgrade)August 16, 2023 | msn.comTD Cowen Maintains Privia Health Group (PRVA) Outperform RecommendationAugust 4, 2023 | finance.yahoo.comIs Privia Health Group, Inc.'s (NASDAQ:PRVA) Stock Price Struggling As A Result Of Its Mixed Financials?August 3, 2023 | finance.yahoo.comPrivia Health (PRVA) Q2 Earnings and Revenues Surpass EstimatesAugust 3, 2023 | finance.yahoo.comPrivia Health Reports Second Quarter 2023 Financial ResultsAugust 1, 2023 | finance.yahoo.comPrivia Health to Enter Washington StateJuly 31, 2023 | finance.yahoo.comPrivia Health Announces Changes to Board of DirectorsJuly 27, 2023 | finance.yahoo.comGEHC vs. PRVA: Which Stock Is the Better Value Option?July 21, 2023 | markets.businessinsider.comPrivia Health Group (PRVA) Receives a Buy from RBC CapitalJuly 18, 2023 | markets.businessinsider.comPrivia Health Group (PRVA) Receives a Buy from Truist FinancialJuly 11, 2023 | finance.yahoo.comPrivia Health to Report Second Quarter 2023 Results on Thursday, August 3June 29, 2023 | finanznachrichten.dePrivia Health Group, Inc.: Privia Health Announces Expansion of and Changes to Board of DirectorsJune 29, 2023 | finance.yahoo.comPrivia Health Announces Expansion of and Changes to Board of DirectorsJune 27, 2023 | finance.yahoo.comShareholders in Privia Health Group (NASDAQ:PRVA) are in the red if they invested a year agoJune 22, 2023 | markets.businessinsider.comPrivia Health Group (PRVA) Gets a Buy from Credit SuisseMay 31, 2023 | msn.comPrivia Health Group: Platform Contribution And Capitated Book Performed StronglyMay 14, 2023 | finance.yahoo.comWith 9.8% one-year returns, institutional owners may ignore Privia Health Group, Inc.'s (NASDAQ:PRVA) 9.2% stock price declineSee More Headlines Receive PRVA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Privia Health Group and its competitors with MarketBeat's FREE daily newsletter. Email Address PRVA Company Calendar Last Earnings8/03/2023Today9/30/2023Next Earnings (Estimated)11/09/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Health services Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:PRVA CUSIPN/A CIK1759655 Webwww.priviahealth.com Phone571-366-8850FaxN/AEmployees964Year FoundedN/APrice Target and Rating Average Stock Price Forecast$36.86 High Stock Price Forecast$43.00 Low Stock Price Forecast$28.00 Forecasted Upside/Downside+60.2%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage10 Analysts Profitability EPS (Most Recent Fiscal Year)$0.27 Trailing P/E Ratio85.19 Forward P/E Ratio104.55 P/E Growth2.85Net Income$-8,590,000.00 Net Margins2.26% Pretax Margin1.02% Return on Equity6.36% Return on Assets3.98% Debt Debt-to-Equity RatioN/A Current Ratio1.82 Quick Ratio1.82 Sales & Book Value Annual Sales$1.36 billion Price / Sales1.99 Cash FlowN/A Price / Cash FlowN/A Book Value$4.53 per share Price / Book5.08Miscellaneous Outstanding Shares117,360,000Free Float49,762,000Market Cap$2.70 billion OptionableNot Optionable Beta0.79 Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesMr. Parth Mehrotra (Age 44)CEO & Director Comp: $1.37MMr. David Mountcastle CPA (Age 52)MBA, Exec. VP, CFO & Principal Accounting Officer Comp: $882.07kMr. Thomas Bartrum (Age 56)Exec. VP & Gen. Counsel Comp: $608.79kMr. Chris VoigtExec. VP & Chief Technology OfficerMr. Robert P. BorchertSr. VP of Investor Relations & Corp. CommunicationsMs. Dana Fields CPASr. VP of Internal Audit & Chief Compliance OfficerMs. Jenny HardingSr. VP of People OperationsMr. Jay StevensSr. VP & Chief Growth OfficerDr. S. Mark Cone FACOG (Age 60)M.D., Pres of Privia Medical Group - Gulf Coast Texas Mr. Eric J. BeyerExec. VP of Medical GroupsMore ExecutivesKey CompetitorsLifeStance Health GroupNASDAQ:LFSTU.S. Physical TherapyNYSE:USPHInnovAgeNASDAQ:INNVPremierNASDAQ:PINCiRhythm TechnologiesNASDAQ:IRTCView All CompetitorsInsiders & InstitutionsWilliam M SullivanSold 18,153 sharesTotal: $454,369.59 ($25.03/share)Thomas BartrumSold 15,000 sharesTotal: $386,550.00 ($25.77/share)William M SullivanSold 18,153 sharesTotal: $480,328.38 ($26.46/share)California State Teachers Retirement SystemBought 29,751 shares on 8/21/2023Ownership: 0.102%Teachers Retirement System of The State of KentuckyBought 30,000 shares on 8/21/2023Ownership: 0.026%View All Insider TransactionsView All Institutional Transactions PRVA Stock - Frequently Asked Questions Should I buy or sell Privia Health Group stock right now? 10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Privia Health Group in the last twelve months. There are currently 10 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" PRVA shares. View PRVA analyst ratings or view top-rated stocks. What is Privia Health Group's stock price forecast for 2023? 10 Wall Street analysts have issued 1-year price targets for Privia Health Group's shares. Their PRVA share price forecasts range from $28.00 to $43.00. On average, they anticipate the company's stock price to reach $36.86 in the next twelve months. This suggests a possible upside of 60.2% from the stock's current price. View analysts price targets for PRVA or view top-rated stocks among Wall Street analysts. How have PRVA shares performed in 2023? Privia Health Group's stock was trading at $22.71 at the beginning of the year. Since then, PRVA stock has increased by 1.3% and is now trading at $23.00. View the best growth stocks for 2023 here. When is Privia Health Group's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, November 9th 2023. View our PRVA earnings forecast. How were Privia Health Group's earnings last quarter? Privia Health Group, Inc. (NASDAQ:PRVA) posted its earnings results on Thursday, August, 3rd. The company reported $0.06 EPS for the quarter, topping the consensus estimate of $0.05 by $0.01. The business had revenue of $413.35 million for the quarter, compared to the consensus estimate of $392.34 million. Privia Health Group had a net margin of 2.26% and a trailing twelve-month return on equity of 6.36%. What ETFs hold Privia Health Group's stock? ETFs with the largest weight of Privia Health Group (NASDAQ:PRVA) stock in their portfolio include Global X Telemedicine & Digital Health ETF (EDOC), Invesco S&P SmallCap Health Care ETF (PSCH), SPDR S&P Health Care Services ETF (XHS), BNY Mellon Innovators ETF (BKIV), ROBO Global Healthcare Technology and Innovation ETF (HTEC), Fidelity Disruptive Medicine ETF (FMED), First Trust Nasdaq Lux Digital Health Solutions ETF (EKG) and Franklin Genomic Advancements ETF (HELX). What guidance has Privia Health Group issued on next quarter's earnings? Privia Health Group updated its FY 2023 earnings guidance on Thursday, August, 3rd. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $1.60 billion-$1.65 billion, compared to the consensus revenue estimate of $1.61 billion. When did Privia Health Group IPO? (PRVA) raised $351 million in an initial public offering (IPO) on Thursday, April 29th 2021. The company issued 19,500,000 shares at a price of $17.00-$19.00 per share. Goldman Sachs, J.P. Morgan, Credit Suisse, Piper Sandler and William Blair acted as the underwriters for the IPO and Canaccord Genuity, Truist Securities, R. Seelaus & Co. and Siebert Williams Shank were co-managers. What is Privia Health Group's stock symbol? Privia Health Group trades on the NASDAQ under the ticker symbol "PRVA." How do I buy shares of Privia Health Group? Shares of PRVA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Privia Health Group's stock price today? One share of PRVA stock can currently be purchased for approximately $23.00. How much money does Privia Health Group make? Privia Health Group (NASDAQ:PRVA) has a market capitalization of $2.70 billion and generates $1.36 billion in revenue each year. The company earns $-8,590,000.00 in net income (profit) each year or $0.27 on an earnings per share basis. How many employees does Privia Health Group have? The company employs 964 workers across the globe. How can I contact Privia Health Group? The official website for the company is www.priviahealth.com. The company can be reached via phone at 571-366-8850 or via email at ir@priviahealth.com. This page (NASDAQ:PRVA) was last updated on 9/30/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Privia Health Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.